483
Retmap IncRetmap Inc – FDA 483, Oct 30, 2025
Record Details
An FDA inspection of Retmap Inc, a manufacturer in Chicago, revealed significant deficiencies across its quality system. Observations included inadequate documentation of equipment maintenance, failure to control nonconforming products, and insufficient supplier management. The firm also lacked proper procedures for corrective and preventive actions, failed to conduct timely management reviews, and did not perform required quality audits.
View Company Profile
ID · 58ebb169-777e-4508-bbd9-d0c470f388be
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.